ESOPJun 1, 2026, 04:30 PM
X4 Pharmaceuticals Grants 160,000 Stock Options to New Employees
AI Summary
X4 Pharmaceuticals announced that it issued inducement awards to new employees, effective May 29, 2026. These awards consist of options to purchase an aggregate of 160,000 shares of the company's common stock under the 2019 Inducement Equity Incentive Plan. The options have an exercise price of $4.31 per share, a ten-year term, and vest over a four-year period, with 25% vesting after 12 months and the remainder monthly over the subsequent 36 months, subject to continued employment.
Key Highlights
- X4 Pharmaceuticals granted options to purchase 160,000 shares of common stock.
- Awards were issued to new employees under the 2019 Inducement Equity Incentive Plan.
- The exercise price for the options is $4.31 per share.
- Options have a ten-year term.
- Vesting schedule: 25% after 12 months, then monthly over the following 36 months.
- Awards were approved by X4's Compensation Committee of the Board of Directors.
Price Impact
More from XFOR